Skip to main content

GNI to Use Gene Regulatory Network Techology in Research Collaboration with Toyama Chemical

NEW YORK, Oct. 11 (GenomeWeb News) - Gene Networks International will provide its gene regulatory network technology platform to Toyama Chemical, the company said today.

 

GNI, which has offices in Kurume, Japan, and Cambridge, UK, has licensed the use of the technology to Toyamaand will provide the company with gene expression data and discovery services.

 

GNI's gene regulatory network maps are based on research at the Universityof Cambridge, KyushuUniversity, and the Universityof Tokyo.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.